Major differences in bleeding symptoms between factor VII deficiency and hemophilia B

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 5, 2009, Pages 774-779

  Bernardi, Francesco ^a   Dolce, A ^b   Pinotti, M ^a   Shapiro, A D ^c   Santagostino, E ^d   Peyvandi, F ^d   Batorova, A ^e   Lapecorella, M ^f   Schved, J F ^g   Ingerslev, J ^h   Mariani, G ^f  

^a UNIVERSITY OF FERRARA   (Italy)

^b ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

^c INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^f UNIVERSITY OF L'AQUILA   (Italy)

^g MONTPELLIER UNIVERSITY HOSPITAL   (France)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bleeding; Disease presenting symptoms; FVII deficiency; Hemophilia B

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9;

ADULT; AGE; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CENTRAL NERVOUS SYSTEM; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; EPISTAXIS; FEMALE; GENE MUTATION; GENOTYPE; HEMATOMA; HEMOPHILIA B; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORAL BLEEDING; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

DISEASE-FREE SURVIVAL; FACTOR VII DEFICIENCY; HEMOPHILIA B; HEMORRHAGE; HUMANS; QUESTIONNAIRES;

EID: 65349161613     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03329.x     Document Type: Article

References (35)

1. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800-6.
2. Dahlbäck B. Blood coagulation. Lancet 2000; 355: 1627-32.
3. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, Ingram JD, Manco-Johnson ML, Funk S, Jacobson L, Valentino LA, Hoots WK, Buchanan GR, DiMichele D, Recht M, Brown D, Leissinger C, Bleak S, Cohen A, Mathew P, et.al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
4. Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735-44.
5. Greaves M, Watson HG. Approach to the diagnosis and management of mild bleeding disorders. J Thromb Haemost 2007; 5: 167-74.
6. Mannucci PM. Hemophilia: Treatment options in the twenty-first century. J Thromb Haemost 2003; 1: 1349-55.
7. Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
8. VandenDriessche T, Collen D, Chuah MKL. Gene therapy for the hemophilias. J Thromb Haemost 2003; 1: 1550-8.
9. Pierce GF, Lillicrap D, Pipe SW, VandenDriessche T. Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment. J Thromb Haemost 2007; 5: 901-6.
10. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
11. Roberts HR, Ma AD. Overview of inherited hemorrhagic disorders. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (Editors). Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 5th edn. Philadelphia USA: Lippincott Williams & Wilkins, 2006: 877-86.
12. Kessler CM, Mariani G. Clinical manifestations and therapy of the Hemophilias. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (Editors). Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 5th edn. Philadelphia USA: Lippincott Williams & Wilkins, 2006: 887-97.
13. Schulman S, Eelde A, Holmström M, Ståhlberg G, Odeberg J, Blombäck M. Validation of a composite score for clinical severity of hemophilia. J Thromb Haemost 2008; 6: 1113-21.
14. O'Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A 1987; 84: 5158-62.
15. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
16. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-80.
17. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
18. van Minkelen R, de Visser MC, van Hylckama Vlieg A, Vos HL, Bertina RM. Sequence variants and haplotypes of the factor IX gene and the risk of venous thrombosis. J Thromb Haemost 2008; 6: 1610-3.
19. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555-64.
20. McVey JH, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EG. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17: 3-17.
21. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F, International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-7.
22. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG. Haemophilia B: database of point mutations and short additions and deletions-8th edition. Nucleic Acids Res 1998; 26: 265-8.
23. Bottema CD, Ketterling RP, Vielhaber E, Yoon HS, Gostout B, Jacobson DP, Shapiro A, Sommer SS. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene. Hum Genet 1993; 91: 496-503.
24. Shapiro AD, Di Paola J, Cohen A, Pasi KJ, Heisel MA, Blanchette VS, Abshire TC, Hoots WK, Lusher JM, Negrier C, Rothschild C, Roth DA. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood 2005; 105: 518-25.
25. Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley, 1977.
26. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31: 3812-4.
27. White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
28. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003; 361: 1801-9.
29. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-6.
30. Pinotti M, Etro D, Bindini D, Papa ML, Rodorigo G, Rocino A, Mariani G, Ciavarella N, Bernardi F. Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser). Blood 2002; 99: 1495-7.
31. Pinotti M, Rizzotto L, Pinton P, Ferraresi P, Chuansumrit A, Charoenkwan P, Marchetti G, Rizzuto R, Mariani G, Bernardi F, International Factor VII Deficiency Study Group. Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII. J Thromb Haemost 2006; 4: 1308-14.
32. Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, Kreuz W, Pollmann H, Nowak-Göttl U. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001; 85: 218-20.
33. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Béguin S, Hemker HC. The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-82.
34. Rosen ED, Chan JC, Idusogie E, Clotman F, Vlasuk G, Luther T, Jalbert LR, Albrecht S, Zhong L, Lissens A, Schoonjans L, Moons L, Collen D, Castellino FJ, Carmeliet P. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997; 390: 290-4.
35. Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 1997; 90: 3962-6.